Evidence of Chemoresponsiveness in Unresectable Metastatic Angiomatoid Fibrous Histiocytoma.
暂无分享,去创建一个
[1] J. Blay,et al. Tocilizumab for the treatment of paraneoplastic inflammatory syndrome associated with angiomatoid fibrous histiocytoma , 2020, ESMO Open.
[2] B. Al-Lazikani,et al. A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations , 2019, European journal of cancer.
[3] B. Naik-Mathuria,et al. Therapeutic response of metastatic angiomatoid fibrous histiocytoma carrying EWSR1‐CREB1 fusion to the interleukin‐6 receptor antibody tocilizumab , 2018, Pediatric blood & cancer.
[4] B. Brennan,et al. Angiomatoid fibrous histiocytoma: A case of local recurrence and metastases to loco‐regional lymph nodes that responded to chemotherapy , 2017, Pediatric blood & cancer.
[5] Kenichi Saito,et al. Angiomatoid fibrous histiocytoma: a series of seven cases including genetically confirmed aggressive cases and a literature review , 2017, BMC Musculoskeletal Disorders.
[6] C. Herzog,et al. Characterization of Metastatic Angiomatoid Fibrous Histiocytoma , 2015, Journal of pediatric hematology/oncology.
[7] C. Fisher,et al. Angiomatoid fibrous histiocytoma: the current status of pathology and genetics. , 2015, Archives of pathology & laboratory medicine.
[8] P. Roux‐Lombard,et al. A simple Baker's cyst? Tocilizumab remits paraneoplastic signs and controls growth of IL-6-producing angiomatoid malignant fibrous histiocytoma. , 2014, Rheumatology.
[9] J. Goldblum,et al. Angiomatoid fibrous histiocytoma: an expansion of the clinical and histological spectrum , 2014, Pathology.
[10] P. Cin,et al. SUPPLEMENT 2 SPECIAL ISSUE: BONE AND SOFT TISSUE , 2012 .
[11] A. Folpe,et al. Angiomatoid fibrous histiocytoma: unusual sites and unusual morphology , 2011, Modern Pathology.
[12] A. Mansfield,et al. Angiomatoid fibrous histiocytoma in a 25-year-old male , 2010, Rare tumors.
[13] T. Yamashita,et al. Angiomatoid fibrous histiocytoma including cases with pleomorphic features analysed by fluorescence in situ hybridisation , 2010, Journal of Clinical Pathology.
[14] H. Tanke,et al. EWSR1-CREB1 and EWSR1-ATF1 Fusion Genes in Angiomatoid Fibrous Histiocytoma , 2007, Clinical Cancer Research.
[15] U. Surti,et al. EWSR1‐CREB1 is the predominant gene fusion in angiomatoid fibrous histiocytoma , 2007, Genes, chromosomes & cancer.
[16] C. Fletcher. The evolving classification of soft tissue tumours: an update based on the new WHO classification , 2006, Histopathology.
[17] I. Panagopoulos,et al. Fusion of the FUS and ATF1 Genes in a Large, Deep-Seated Angiomatoid Fibrous Histiocytoma , 2002, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[18] M. Miettinen,et al. Angiomatoid "malignant" fibrous histiocytoma: a clinicopathologic study of 158 cases and further exploration of the myoid phenotype. , 1999, Human pathology.
[19] N. Winick,et al. Adjuvant chemotherapy for treatment of unresectable and metastatic angiomatoid malignant fibrous histiocytoma , 1994, Cancer.
[20] Michael J. Costa,et al. Angiomatoid Malignant Fibrous Histiocytoma: A Follow‐up Study of 108 Cases with Evaluation of Possible Histologic Predictors of Outcome , 1990, The American journal of surgical pathology.
[21] G. de Rosa,et al. Angiomatoid malignant fibrous histiocytoma: cytologic, immunohistochemical, ultrastructural, and flow cytometric study of 20 cases. , 1990, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.